Literature DB >> 11200070

Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells.

K Kerekes1, P D Cooper, J Prechl, M Józsi, Z Bajtay, A Erdei.   

Abstract

The adjuvant effect of gamma-inulin, a strong activator of the alternative complement pathway, is well-known, but its exact mechanism is not revealed yet. Here, we show that macrophages, isolated from the peritoneal cavity of gamma-inulin-injected mice and used as antigen-presenting cells, enhance the proliferation of antigen-specific T-cells up to 2.5-fold when compared with macrophages of non-treated animals. This effect is abrogated by the presence of anti-C3 F(ab')2 fragments and by prior decomplementation of the donor animals with CVF. It is demonstrated that treatment of mice with the adjuvant results in deposition of C3-fragments onto the surface of peritoneal macrophages, as does in vitro incubation of the cells with gamma-inulin in the presence of fresh autologous serum. Prior incubation of macrophages with gamma-inulin plus serum in vitro enhances subsequent C3 production. Because it has been shown earlier that CR1/2 expressed on activated T-cells and interacting with covalently bound C3-fragments plays an important role in the augmentation of the adaptive response, our present results reveal a mechanism that contributes to the adjuvant effect of gamma-inulin and point to a further link between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11200070

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Authors:  Qing Ma; Dan Li; Roza Nurieva; Rebecca Patenia; Roland Bassett; Wei Cao; Andrei M Alekseev; Hong He; Jeffrey J Molldrem; Michael H Kroll; Richard E Champlin; George E Sale; Vahid Afshar-Kharghan
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-01       Impact factor: 5.742

Review 2.  Complement's hidden arsenal: New insights and novel functions inside the cell.

Authors:  M Kathryn Liszewski; Michelle Elvington; Hrishikesh S Kulkarni; John P Atkinson
Journal:  Mol Immunol       Date:  2017-02-10       Impact factor: 4.407

Review 3.  The role of the complement system in cancer.

Authors:  Vahid Afshar-Kharghan
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Authors:  Peter D Cooper; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2010-12-07       Impact factor: 4.313

Review 5.  Role and mechanism of action of complement in regulating T cell immunity.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Mol Immunol       Date:  2010-06-18       Impact factor: 4.407

6.  Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

Authors:  Q Ma; D Li; R Carreño; R Patenia; K Y Tsai; M Xydes-Smith; A M Alousi; R E Champlin; G E Sale; V Afshar-Kharghan
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 7.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

8.  Complement-mediated 'bystander' damage initiates host NLRP3 inflammasome activation.

Authors:  Rahul Suresh; Prabha Chandrasekaran; Fayyaz S Sutterwala; David M Mosser
Journal:  J Cell Sci       Date:  2016-03-22       Impact factor: 5.285

9.  Decay-accelerating factor modulates induction of T cell immunity.

Authors:  Peter S Heeger; Peter N Lalli; Feng Lin; Anna Valujskikh; Jinbo Liu; Nasima Muqim; Yuanyuan Xu; M Edward Medof
Journal:  J Exp Med       Date:  2005-05-09       Impact factor: 14.307

10.  Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.

Authors:  M Korbelik; P D Cooper
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.